fda warning letters glp-1 september 2025 news issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's crackdown on misleading Novo Hit With FDA Warning

Reported spending shifts toward wellness and lifestyle Across both markets, GLP-1 users in this study report shifting spending away from restaurants and indulgent categories and toward clothing, fitness, personal care, and health-related products

This is where digital health companies have started to pave the way by offering wraparound care

Even the World Health Organization looks like it's destined to pull a U-turn on recommending them

Diyabet olmakszn sadece kilo vermek iin kullanlan bu tedavi, Hollanda'da yalnzca kat koullar altnda geri denmektedir

However, developers of GLP-2 therapies for chronic IBD will need to address prescriber concerns regarding long-term trophic effects and the necessity for mucosal dysplasia surveillance